Condition: Healthcare-Associated Pneumonia · Ventilator Associated Pneumonia · Sponsor: Instituto de Assistencia Medica ao Servidor Publico Estadual, Sao Paulo
The use of corticosteroids in patients with severe community pneumonia, bacterial infection which kills lots of patients around the world, reduces the mortality of this infection. However, there are no studies with this type of drug regarding hospital-acquired pneumonia. This is the first multicenter randomized trial to test hydrocortisone plus standard therapy in critical care patients with nosocomial pneumonia. This intervention is inexpensive and may improve the outcome of those patients, besides having an acceptable side effects profile.
This description comes directly from the study's public registry record.
Dante Raglione, MD · 5511984471792 · danraglione@gmail.com
Always discuss trial participation with your own doctor first.
| Hospital do Servidor Publico Estadual | São Paulo, Sao Paulo SP, Brazil | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05354778